Salt Lake City,
Utah - The trial of the lawsuit filed in August 2004 on
behalf of the U.S. Food and Drug Administration (FDA) alleging Quality
System Regulation (QSR) violations by Utah Medical Products, Inc. (Nasdaq:
UTMD) is scheduled to begin on September 26, 2005 in the U.S. District Court
in Salt Lake City, Judge Bruce S. Jenkins presiding.
The trial will focus on UTMD’s compliance with the QSR. On September 19,
2005, lawyers for UTMD will file a pretrial brief and proposed findings of
fact and conclusions of law for the Court to consider. The Company will
provide a copy of UTMD’s pretrial brief and proposed findings of fact and
conclusions of law to investors who request it by calling Paul Richins at
(800) 533-4984 or (801) 566-1200.
UTMD’s administrative claim for damages concerning alleged FDA misconduct
was submitted to the Department of Health and Human Services in July. The
FDA has until January 8, 2006 to consider UTMD’s claim for damages.
Accordingly, UTMD’s damages claim will not be addressed at the currently
Utah Medical Products, Inc., with particular interest in health care for
women and their babies, develops, manufactures, assembles and markets a
broad range of well-established, safe and effective, disposable and reusable
specialty medical devices.